Neuro-Bio have now begun a research collaboration with DIANA Biotechnologies based in Prague. The technology is detailed below, but briefly: The technology makes use of the amplifying properties in a polymerase chain reaction, combined with a quantitative analysis (qPCR). In this way sensitivity to molecules in the zeptomolar range are possible. It will be used to quantify levels of T14 in plasma samples from equal numbers of control and AD subjects.